Compare GLU & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLU | TMCI |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.8M | 120.4M |
| IPO Year | N/A | 2021 |
| Metric | GLU | TMCI |
|---|---|---|
| Price | $19.18 | $4.17 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.77 |
| AVG Volume (30 Days) | 7.4K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 8.60% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.18 |
| P/E Ratio | $31.13 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $17.11 | $1.17 |
| 52 Week High | $21.69 | $7.78 |
| Indicator | GLU | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 58.25 |
| Support Level | $19.13 | $2.46 |
| Resistance Level | $20.17 | $4.47 |
| Average True Range (ATR) | 0.31 | 0.43 |
| MACD | 0.07 | -0.06 |
| Stochastic Oscillator | 96.10 | 44.39 |
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.